Trials / Completed
CompletedNCT04857385
Radial Artery Puncture Hemostasis Study
Radial Artery Puncture Hemostasis: Physical, Biological and Chemical Methods
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 600 (actual)
- Sponsor
- Semmelweis University Heart and Vascular Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
RAPHE is an open label randomized clinical trial to assess physical, biological and chemical methods of radial artery puncture hemostasis following coronary catheterization. A total of 600 subjects will be randomized in a 1:1:1 fashion to either the StatSeal, Axiostat or TR Band hemostasis devices. Follow-up of the subject will take place 60 days after the index procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Radial artery hemostasis | Each of the devices will be assessed for radial artery hemostasis. |
Timeline
- Start date
- 2021-04-14
- Primary completion
- 2024-01-01
- Completion
- 2024-01-01
- First posted
- 2021-04-23
- Last updated
- 2024-04-17
Locations
3 sites across 1 country: Hungary
Source: ClinicalTrials.gov record NCT04857385. Inclusion in this directory is not an endorsement.